http://streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 13 May 2026 09:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Biofrontera+Launches+Second+Annual+%E2%80%9CHats+On%E2%80%9D+Campaign+to+Raise+Awareness+of+Actinic+Keratosis/26482718.html <ul type="disc"><li style="text-align:justify;">The second annual #HatsonforAK Campaign runs May 18–24, 2026, culminating on Global Actinic Keratosis (AK) Awareness Day</li><li style="text-align:justify;">This social media–driven initiative invites people to wear a hat, share a photo, and help raise awareness of AK and the importance of comprehensive sun protection</li><li style="text-align:justify;">Actinic Keratosis affects an estimated 58 million Americans and, if left untreated, can develop into squamous cell carcinoma1<br/><br/></li></ul> <p align="justify"><strong>Woburn, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- </strong>Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), today announced the return http://www.streetinsider.com/Press+Releases/Biofrontera+Launches+Second+Annual+%E2%80%9CHats+On%E2%80%9D+Campaign+to+Raise+Awareness+of+Actinic+Keratosis/26482718.html Wed, 13 May 2026 09:00:00 -0400 A.60012011 BFRI BFRIW O.00019052 O.52535366 http://www.streetinsider.com/Press+Releases/Biofrontera+Launches+Second+Annual+%E2%80%9CHats+On%E2%80%9D+Campaign+to+Raise+Awareness+of+Actinic+Keratosis/26482718.html <ul type="disc"><li style="text-align:justify;">The second annual #HatsonforAK Campaign runs May 18–24, 2026, culminating on Global Actinic Keratosis (AK) Awareness Day</li><li style="text-align:justify;">This social media–driven initiative invites people to wear a hat, share a photo, and help raise awareness of AK and the importance of comprehensive sun protection</li><li style="text-align:justify;">Actinic Keratosis affects an estimated 58 million Americans and, if left untreated, can develop into squamous cell carcinoma1<br/><br/></li></ul> <p align="justify"><strong>Woburn, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- </strong>Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), today announced the return http://www.streetinsider.com/Press+Releases/Biofrontera+Launches+Second+Annual+%E2%80%9CHats+On%E2%80%9D+Campaign+to+Raise+Awareness+of+Actinic+Keratosis/26482718.html Wed, 13 May 2026 09:00:00 -0400 A.60012011 BFRI BFRIW O.00019052 O.52535366 http://www.streetinsider.com/Press+Releases/Biofrontera+Launches+Second+Annual+%E2%80%9CHats+On%E2%80%9D+Campaign+to+Raise+Awareness+of+Actinic+Keratosis/26482718.html <ul type="disc"><li style="text-align:justify;">The second annual #HatsonforAK Campaign runs May 18–24, 2026, culminating on Global Actinic Keratosis (AK) Awareness Day</li><li style="text-align:justify;">This social media–driven initiative invites people to wear a hat, share a photo, and help raise awareness of AK and the importance of comprehensive sun protection</li><li style="text-align:justify;">Actinic Keratosis affects an estimated 58 million Americans and, if left untreated, can develop into squamous cell carcinoma1<br/><br/></li></ul> <p align="justify"><strong>Woburn, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- </strong>Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), today announced the return http://www.streetinsider.com/Press+Releases/Biofrontera+Launches+Second+Annual+%E2%80%9CHats+On%E2%80%9D+Campaign+to+Raise+Awareness+of+Actinic+Keratosis/26482718.html Wed, 13 May 2026 09:00:00 -0400 A.60012011 BFRI BFRIW O.00019052 O.52535366 http://www.streetinsider.com/Press+Releases/Biofrontera+Launches+Second+Annual+%E2%80%9CHats+On%E2%80%9D+Campaign+to+Raise+Awareness+of+Actinic+Keratosis/26482718.html <ul type="disc"><li style="text-align:justify;">The second annual #HatsonforAK Campaign runs May 18–24, 2026, culminating on Global Actinic Keratosis (AK) Awareness Day</li><li style="text-align:justify;">This social media–driven initiative invites people to wear a hat, share a photo, and help raise awareness of AK and the importance of comprehensive sun protection</li><li style="text-align:justify;">Actinic Keratosis affects an estimated 58 million Americans and, if left untreated, can develop into squamous cell carcinoma1<br/><br/></li></ul> <p align="justify"><strong>Woburn, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- </strong>Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), today announced the return http://www.streetinsider.com/Press+Releases/Biofrontera+Launches+Second+Annual+%E2%80%9CHats+On%E2%80%9D+Campaign+to+Raise+Awareness+of+Actinic+Keratosis/26482718.html Wed, 13 May 2026 09:00:00 -0400 A.60012011 BFRI BFRIW O.00019052 O.52535366 http://www.streetinsider.com/Press+Releases/Biofrontera+Launches+Second+Annual+%E2%80%9CHats+On%E2%80%9D+Campaign+to+Raise+Awareness+of+Actinic+Keratosis/26482718.html <ul type="disc"><li style="text-align:justify;">The second annual #HatsonforAK Campaign runs May 18–24, 2026, culminating on Global Actinic Keratosis (AK) Awareness Day</li><li style="text-align:justify;">This social media–driven initiative invites people to wear a hat, share a photo, and help raise awareness of AK and the importance of comprehensive sun protection</li><li style="text-align:justify;">Actinic Keratosis affects an estimated 58 million Americans and, if left untreated, can develop into squamous cell carcinoma1<br/><br/></li></ul> <p align="justify"><strong>Woburn, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- </strong>Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), today announced the return http://www.streetinsider.com/Press+Releases/Biofrontera+Launches+Second+Annual+%E2%80%9CHats+On%E2%80%9D+Campaign+to+Raise+Awareness+of+Actinic+Keratosis/26482718.html Wed, 13 May 2026 09:00:00 -0400 A.60012011 BFRI BFRIW O.00019052 O.52535366 http://www.streetinsider.com/Globe+Newswire/Biofrontera+Launches+Second+Annual+%E2%80%9CHats+On%E2%80%9D+Campaign+to+Raise+Awareness+of+Actinic+Keratosis/26482718.html <ul type="disc"><li style="text-align:justify;">The second annual #HatsonforAK Campaign runs May 18–24, 2026, culminating on Global Actinic Keratosis (AK) Awareness Day</li><li style="text-align:justify;">This social media–driven initiative invites people to wear a hat, share a photo, and help raise awareness of AK and the importance of comprehensive sun protection</li><li style="text-align:justify;">Actinic Keratosis affects an estimated 58 million Americans and, if left untreated, can develop into squamous cell carcinoma1<br/><br/></li></ul> <p align="justify"><strong>Woburn, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- </strong>Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), today announced the return http://www.streetinsider.com/Globe+Newswire/Biofrontera+Launches+Second+Annual+%E2%80%9CHats+On%E2%80%9D+Campaign+to+Raise+Awareness+of+Actinic+Keratosis/26482718.html Wed, 13 May 2026 09:00:00 -0400 A.60012011 BFRI BFRIW O.00019052 O.52535366 http://www.streetinsider.com/Globe+Newswire/Biofrontera+Launches+Second+Annual+%E2%80%9CHats+On%E2%80%9D+Campaign+to+Raise+Awareness+of+Actinic+Keratosis/26482718.html <ul type="disc"><li style="text-align:justify;">The second annual #HatsonforAK Campaign runs May 18–24, 2026, culminating on Global Actinic Keratosis (AK) Awareness Day</li><li style="text-align:justify;">This social media–driven initiative invites people to wear a hat, share a photo, and help raise awareness of AK and the importance of comprehensive sun protection</li><li style="text-align:justify;">Actinic Keratosis affects an estimated 58 million Americans and, if left untreated, can develop into squamous cell carcinoma1<br/><br/></li></ul> <p align="justify"><strong>Woburn, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- </strong>Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), today announced the return http://www.streetinsider.com/Globe+Newswire/Biofrontera+Launches+Second+Annual+%E2%80%9CHats+On%E2%80%9D+Campaign+to+Raise+Awareness+of+Actinic+Keratosis/26482718.html Wed, 13 May 2026 09:00:00 -0400 A.60012011 BFRI BFRIW O.00019052 O.52535366 http://www.streetinsider.com/Globe+Newswire/Biofrontera+Launches+Second+Annual+%E2%80%9CHats+On%E2%80%9D+Campaign+to+Raise+Awareness+of+Actinic+Keratosis/26482718.html <ul type="disc"><li style="text-align:justify;">The second annual #HatsonforAK Campaign runs May 18–24, 2026, culminating on Global Actinic Keratosis (AK) Awareness Day</li><li style="text-align:justify;">This social media–driven initiative invites people to wear a hat, share a photo, and help raise awareness of AK and the importance of comprehensive sun protection</li><li style="text-align:justify;">Actinic Keratosis affects an estimated 58 million Americans and, if left untreated, can develop into squamous cell carcinoma1<br/><br/></li></ul> <p align="justify"><strong>Woburn, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- </strong>Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), today announced the return http://www.streetinsider.com/Globe+Newswire/Biofrontera+Launches+Second+Annual+%E2%80%9CHats+On%E2%80%9D+Campaign+to+Raise+Awareness+of+Actinic+Keratosis/26482718.html Wed, 13 May 2026 09:00:00 -0400 A.60012011 BFRI BFRIW O.00019052 O.52535366 http://www.streetinsider.com/Globe+Newswire/Biofrontera+Launches+Second+Annual+%E2%80%9CHats+On%E2%80%9D+Campaign+to+Raise+Awareness+of+Actinic+Keratosis/26482718.html <ul type="disc"><li style="text-align:justify;">The second annual #HatsonforAK Campaign runs May 18–24, 2026, culminating on Global Actinic Keratosis (AK) Awareness Day</li><li style="text-align:justify;">This social media–driven initiative invites people to wear a hat, share a photo, and help raise awareness of AK and the importance of comprehensive sun protection</li><li style="text-align:justify;">Actinic Keratosis affects an estimated 58 million Americans and, if left untreated, can develop into squamous cell carcinoma1<br/><br/></li></ul> <p align="justify"><strong>Woburn, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- </strong>Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), today announced the return http://www.streetinsider.com/Globe+Newswire/Biofrontera+Launches+Second+Annual+%E2%80%9CHats+On%E2%80%9D+Campaign+to+Raise+Awareness+of+Actinic+Keratosis/26482718.html Wed, 13 May 2026 09:00:00 -0400 A.60012011 BFRI BFRIW O.00019052 O.52535366 http://www.streetinsider.com/Globe+Newswire/Biofrontera+Launches+Second+Annual+%E2%80%9CHats+On%E2%80%9D+Campaign+to+Raise+Awareness+of+Actinic+Keratosis/26482718.html <ul type="disc"><li style="text-align:justify;">The second annual #HatsonforAK Campaign runs May 18–24, 2026, culminating on Global Actinic Keratosis (AK) Awareness Day</li><li style="text-align:justify;">This social media–driven initiative invites people to wear a hat, share a photo, and help raise awareness of AK and the importance of comprehensive sun protection</li><li style="text-align:justify;">Actinic Keratosis affects an estimated 58 million Americans and, if left untreated, can develop into squamous cell carcinoma1<br/><br/></li></ul> <p align="justify"><strong>Woburn, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- </strong>Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), today announced the return http://www.streetinsider.com/Globe+Newswire/Biofrontera+Launches+Second+Annual+%E2%80%9CHats+On%E2%80%9D+Campaign+to+Raise+Awareness+of+Actinic+Keratosis/26482718.html Wed, 13 May 2026 09:00:00 -0400 A.60012011 BFRI BFRIW O.00019052 O.52535366 http://www.streetinsider.com/Press+Releases/Biofrontera+Inc.+Engages+Lytham+Partners+to+Lead+Strategic+Investor+Relations+and+Shareholder+Communication+Program/25364363.html <p align="justify"><strong>WOBURN, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”)</strong>, a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), has engaged Lytham Partners to lead a strategic investor relations and shareholder communication program.</p> <p align="justify">For more than 20 years, Lytham Partners has been one of the country&apos;s leading investor relations firms, having created one of the industry&apos;s largest and most diverse networks of institutional investors, while creating a framework of best practices in all aspects of corporate and shareholder communications. In addition to their relationships with http://www.streetinsider.com/Press+Releases/Biofrontera+Inc.+Engages+Lytham+Partners+to+Lead+Strategic+Investor+Relations+and+Shareholder+Communication+Program/25364363.html Tue, 23 Sep 2025 09:20:00 -0400 BFRI BFRIW O.52535366 http://www.streetinsider.com/Press+Releases/Biofrontera+Inc.+Engages+Lytham+Partners+to+Lead+Strategic+Investor+Relations+and+Shareholder+Communication+Program/25364363.html <p align="justify"><strong>WOBURN, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”)</strong>, a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), has engaged Lytham Partners to lead a strategic investor relations and shareholder communication program.</p> <p align="justify">For more than 20 years, Lytham Partners has been one of the country&apos;s leading investor relations firms, having created one of the industry&apos;s largest and most diverse networks of institutional investors, while creating a framework of best practices in all aspects of corporate and shareholder communications. In addition to their relationships with http://www.streetinsider.com/Press+Releases/Biofrontera+Inc.+Engages+Lytham+Partners+to+Lead+Strategic+Investor+Relations+and+Shareholder+Communication+Program/25364363.html Tue, 23 Sep 2025 09:20:00 -0400 BFRI BFRIW O.52535366 http://www.streetinsider.com/Press+Releases/Biofrontera+Inc.+Engages+Lytham+Partners+to+Lead+Strategic+Investor+Relations+and+Shareholder+Communication+Program/25364363.html <p align="justify"><strong>WOBURN, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”)</strong>, a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), has engaged Lytham Partners to lead a strategic investor relations and shareholder communication program.</p> <p align="justify">For more than 20 years, Lytham Partners has been one of the country&apos;s leading investor relations firms, having created one of the industry&apos;s largest and most diverse networks of institutional investors, while creating a framework of best practices in all aspects of corporate and shareholder communications. In addition to their relationships with http://www.streetinsider.com/Press+Releases/Biofrontera+Inc.+Engages+Lytham+Partners+to+Lead+Strategic+Investor+Relations+and+Shareholder+Communication+Program/25364363.html Tue, 23 Sep 2025 09:20:00 -0400 BFRI BFRIW O.52535366 http://www.streetinsider.com/Globe+Newswire/Biofrontera+Inc.+Engages+Lytham+Partners+to+Lead+Strategic+Investor+Relations+and+Shareholder+Communication+Program/25364363.html <p align="justify"><strong>WOBURN, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”)</strong>, a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), has engaged Lytham Partners to lead a strategic investor relations and shareholder communication program.</p> <p align="justify">For more than 20 years, Lytham Partners has been one of the country&apos;s leading investor relations firms, having created one of the industry&apos;s largest and most diverse networks of institutional investors, while creating a framework of best practices in all aspects of corporate and shareholder communications. In addition to their relationships with http://www.streetinsider.com/Globe+Newswire/Biofrontera+Inc.+Engages+Lytham+Partners+to+Lead+Strategic+Investor+Relations+and+Shareholder+Communication+Program/25364363.html Tue, 23 Sep 2025 09:20:00 -0400 BFRI BFRIW O.52535366 http://www.streetinsider.com/Globe+Newswire/Biofrontera+Inc.+Engages+Lytham+Partners+to+Lead+Strategic+Investor+Relations+and+Shareholder+Communication+Program/25364363.html <p align="justify"><strong>WOBURN, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”)</strong>, a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), has engaged Lytham Partners to lead a strategic investor relations and shareholder communication program.</p> <p align="justify">For more than 20 years, Lytham Partners has been one of the country&apos;s leading investor relations firms, having created one of the industry&apos;s largest and most diverse networks of institutional investors, while creating a framework of best practices in all aspects of corporate and shareholder communications. In addition to their relationships with http://www.streetinsider.com/Globe+Newswire/Biofrontera+Inc.+Engages+Lytham+Partners+to+Lead+Strategic+Investor+Relations+and+Shareholder+Communication+Program/25364363.html Tue, 23 Sep 2025 09:20:00 -0400 BFRI BFRIW O.52535366 http://www.streetinsider.com/Globe+Newswire/Biofrontera+Inc.+Engages+Lytham+Partners+to+Lead+Strategic+Investor+Relations+and+Shareholder+Communication+Program/25364363.html <p align="justify"><strong>WOBURN, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”)</strong>, a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), has engaged Lytham Partners to lead a strategic investor relations and shareholder communication program.</p> <p align="justify">For more than 20 years, Lytham Partners has been one of the country&apos;s leading investor relations firms, having created one of the industry&apos;s largest and most diverse networks of institutional investors, while creating a framework of best practices in all aspects of corporate and shareholder communications. In addition to their relationships with http://www.streetinsider.com/Globe+Newswire/Biofrontera+Inc.+Engages+Lytham+Partners+to+Lead+Strategic+Investor+Relations+and+Shareholder+Communication+Program/25364363.html Tue, 23 Sep 2025 09:20:00 -0400 BFRI BFRIW O.52535366